Follow
Ignace Vergote
Ignace Vergote
Professor of Gynecologic Oncology, University of Leuven
Verified email at uzleuven.be
Title
Cited by
Cited by
Year
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer
I Vergote, CG Tropé, F Amant, GB Kristensen, T Ehlen, N Johnson, ...
New England Journal of Medicine 363 (10), 943-953, 2010
22292010
Endometrial cancer
F Amant, P Moerman, P Neven, D Timmerman, E Van Limbergen, ...
The Lancet 366 (9484), 491-505, 2005
20932005
Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer
MR Mirza, BJ Monk, J Herrstedt, AM Oza, S Mahner, A Redondo, ...
New England Journal of Medicine 375 (22), 2154-2164, 2016
17922016
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer
J Ledermann, P Harter, C Gourley, M Friedlander, I Vergote, G Rustin, ...
New England Journal of Medicine 366 (15), 1382-1392, 2012
17692012
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised …
J Ledermann, P Harter, C Gourley, M Friedlander, I Vergote, G Rustin, ...
The lancet oncology 15 (8), 852-861, 2014
14552014
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial
E Pujade-Lauraine, F Hilpert, B Weber, A Reuss, A Poveda, G Kristensen, ...
Obstetrical & Gynecological Survey 69 (7), 402-404, 2014
13592014
Randomized intergroup trial of cisplatin–paclitaxel versus cisplatin–cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results
MJ Piccart, K Bertelsen, K James, J Cassidy, C Mangioni, E Simonsen, ...
Journal of the National Cancer Institute 92 (9), 699-708, 2000
12322000
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised …
E Pujade-Lauraine, JA Ledermann, F Selle, V Gebski, RT Penson, ...
The lancet oncology 18 (9), 1274-1284, 2017
11992017
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ...
The Lancet 390 (10106), 1949-1961, 2017
11182017
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and …
J Bonneterre, B Thürlimann, JFR Robertson, M Krzakowski, L Mauriac, ...
Journal of Clinical Oncology 18 (22), 3748-3757, 2000
10752000
Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group
D Timmerman, L Valentin, TH Bourne, WP Collins, H Verrelst, I Vergote
Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 2000
8902000
Niraparib in patients with newly diagnosed advanced ovarian cancer
A González-Martín, B Pothuri, I Vergote, R DePont Christensen, ...
New England Journal of Medicine 381 (25), 2391-2402, 2019
8822019
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment
A Howell, JFR Robertson, J Quaresma Albano, A Aschermannova, ...
Journal of Clinical Oncology 20 (16), 3396-3403, 2002
8262002
Sentinel node dissection is safe in the treatment of early-stage vulvar cancer.
AG Van der Zee, MH Oonk, JA De Hullu, AC Ansink, I Vergote, ...
8082008
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the …
J Pfisterer, M Plante, I Vergote, A du Bois, H Hirte, AJ Lacave, U Wagner, ...
Journal of Clinical Oncology 24 (29), 4699-4707, 2006
7672006
Olaparib plus bevacizumab as first-line maintenance in ovarian cancer
I Ray-Coquard, P Pautier, S Pignata, D Pérol, A González-Martín, ...
New England Journal of Medicine 381 (25), 2416-2428, 2019
7472019
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
I Vergote, J De Brabanter, A Fyles, K Bertelsen, N Einhorn, P Sevelda, ...
The lancet 357 (9251), 176-182, 2001
7452001
Epithelial ovarian cancer
S Lheureux, C Gourley, I Vergote, AM Oza
The Lancet 393 (10177), 1240-1253, 2019
6952019
Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse
E Pujade-Lauraine, U Wagner, E Aavall-Lundqvist, V Gebski, M Heywood, ...
Journal of clinical oncology 28 (20), 3323-3329, 2010
6242010
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
5962013
The system can't perform the operation now. Try again later.
Articles 1–20